Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway
Victoria M Pak1, S-Hakki Onen2,3, Donald L Bliwise4
1Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, United States.
Frontiers in Aging Neuroscience
|May 28, 2020
Summary
Sleep disturbances are common in mild cognitive impairment (MCI) and Alzheimer's disease (AD). This review explores the link between sleep issues and neuroinflammation in MCI and AD, seeking prevention targets.
Area of Science:
- Neuroscience
- Gerontology
- Sleep Medicine
Background:
- Mild cognitive impairment (MCI) and Alzheimer's disease (AD) are prevalent in the elderly.
- Sleep disturbances are frequently observed in individuals with MCI and AD.
- Neuroinflammation is a key feature in the pathology of MCI and AD.
Purpose of the Study:
- To review current research on the relationship between sleep disturbances and neuroinflammation in MCI and AD.
- To explore potential pathways linking sleep and AD pathology.
- To identify the temporal relationship between sleep disturbances and AD progression.
Main Methods:
- Systematic literature review of studies investigating sleep disturbances and neuroinflammation in MCI and AD.
- Analysis of existing evidence on the bidirectional relationship between sleep, neuroinflammation, and cognitive decline.
- Synthesis of findings to understand the temporal dynamics of these factors.
Main Results:
- Strong evidence suggests multiple pathways connect sleep disturbances to AD pathology.
- Neuroinflammation is implicated in the progression of both MCI and AD.
- The precise temporal order of sleep disturbances and neuroinflammation in AD pathogenesis remains unclear.
Conclusions:
- Understanding the interplay between sleep disturbances and neuroinflammation is crucial for MCI and AD.
- Further research is needed to elucidate the temporal direction of the sleep-AD relationship.
- Identifying therapeutic targets for sleep and neuroinflammation may offer novel prevention strategies for MCI and AD.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Role of Neurotransmitters in Memory
2.2K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.2K
Alzheimer's Disease: Treatment
680
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
680
Neural Regulation
42.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.9K


